Perseus Holdings USA, an immuno-oncology company focused on the development and commercialization of next-generation, immune-mediated technologies for the treatment of cancer, announced the appointment of Ben “Bud” M. Brigham to its board of directors, effective immediately.
September 15, 2020
· 4 min read